Sellas Life Sciences Group
Clinical trials sponsored by Sellas Life Sciences Group, explained in plain language.
-
Last-Resort treatment option opens for blood cancer patients
Disease control AVAILABLEThis program offers galinpepimut-S, an experimental immune therapy, to individual patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who have run out of standard treatments. It is for those who cannot join a clinical trial and have no other suitable opti…
Sponsor: Sellas Life Sciences Group • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new drug called SLS009 (formerly GFH009) in people with blood cancers like leukemia and lymphoma that have come back or not responded to treatment. The drug is given alone or with other cancer medicines (venetoclax and azacitidine). The goal is to see if it is …
Phase: PHASE1, PHASE2 • Sponsor: Sellas Life Sciences Group • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC